Evidence map›Paper›PMID 38404704›Full record

ArticleCanada communicable disease report = Releve des maladies transmissibles au Canada2023

Coupling wastewater-based epidemiological surveillance and modelling of SARS-COV-2/COVID-19: Practical applications at the Public Health Agency of Canada.

Meong Jin Joung, Chand S Mangat, Edgard M Mejia, Audra Nagasawa, Anil Nichani, Carol Perez-Iratxeta, Shelley W Peterson, David Champredon

Open access · diamondAbstract read
In one paragraph

Article in Canada communicable disease report = Releve des maladies transmissibles au Canada, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Meong Jin JoungNational Microbiology Laboratory, Public Health Risk Sciences Division, Public Health Agency of Canada, Guelph, ON.
Chand S MangatNational Microbiology Laboratory, Wastewater Surveillance Unit, Public Health Agency of Canada, Winnipeg, MB.
Edgard M MejiaNational Microbiology Laboratory, Wastewater Surveillance Unit, Public Health Agency of Canada, Winnipeg, MB.
Audra NagasawaStatistics Canada, Centre for Direct Health Measures, Ottawa, ON.
Anil NichaniNational Microbiology Laboratory, Public Health Agency of Canada, Guelph, ON.
Carol Perez-IratxetaStatistics Canada, Centre for Direct Health Measures, Ottawa, ON.
Shelley W PetersonNational Microbiology Laboratory, Wastewater Surveillance Unit, Public Health Agency of Canada, Winnipeg, MB.
David ChampredonNational Microbiology Laboratory, Public Health Risk Sciences Division, Public Health Agency of Canada, Guelph, ON.
Public Health Agency of Canada · CAStatistics Canada · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Wastewater-based surveillance (WBS) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) offers a complementary tool for clinical surveillance to detect and monitor coronavirus disease 2019 (COVID-19). Since both symptomatic and asymptomatic individuals infected with SARS-CoV-2 can shed the virus through the fecal route, WBS has the potential to measure community prevalence of COVID-19 without restrictions from healthcare-seeking behaviours and clinical testing capacity. During the Omicron wave, the limited capacity of clinical testing to identify COVID-19 cases in many jurisdictions highlighted the utility of WBS to estimate disease prevalence and inform public health strategies; however, there is a plethora of in-sewage, environmental and laboratory factors that can influence WBS outcomes. The implementation of WBS, therefore, requires a comprehensive framework to outline a pipeline that accounts for these complex and nuanced factors. This article reviews the framework of the national WBS conducted at the Public Health Agency of Canada to present WBS methods used in Canada to track and monitor SARS-CoV-2. In particular, we focus on five Canadian cities-Vancouver, Edmonton, Toronto, Montréal and Halifax-whose wastewater signals are analyzed by a mathematical model to provide case forecasts and reproduction number estimates. The goal of this work is to share our insights on approaches to implement WBS. Importantly, the national WBS system has implications beyond COVID-19, as a similar framework can be applied to monitor other infectious disease pathogens or antimicrobial resistance in the community.

Indexed as

COVID-19environmental surveillanceepidemiologymathematical modellingpandemicSARS-CoV-2wastewater

Identifiers

PMID38404704
PMCPMC10890812
OpenAlexW4378904450

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.